Back to company

LICA PHARMACEUTICALS ApS: Financial statements 2018

CVR: 25332520

LICA PHARMACEUTICALS ApS (CVR 25332520) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 973,018 and a net result of DKK 5,572,310 compared with DKK 812,469 the year before. That is an increase of 138.1% compared with the year before. Equity amounted to DKK 18,367,765. The solvency ratio was 99.5%.

Gross Profit
973,018 kr.
Profit/Loss
5,572,310 kr.
Equity
18,367,765 kr.
Total Assets
18,457,147 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2018-973 t.5.6 mio.18.4 mio.-
2017-409 t.812 t.12.8 mio.-
2016-738 t.328 t.12 mio.-
2015-312 t.-2.3 mio.11.7 mio.-
2014-269 t.3.9 mio.13.9 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on LICA PHARMACEUTICALS ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2018

LICA PHARMACEUTICALS ApS: The 2017 annual report is outApr 16, 2018

LICA PHARMACEUTICALS ApS has published its annual report for 2017. Gross profit came to DKK 408,690, and the net result was DKK 812,469.

About LICA PHARMACEUTICALS ApS

LICA PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2000. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named LICA PHARMACEUTICALS A/S. The management consists of Arsalan Kharazmi. The company is owned by Arsalan Kharazmi. The company has 1 employee. In 2025, the company reported a gross profit of DKK 359,449 and a net result of DKK 450,710 compared with DKK 1,406,816 the year before. Equity amounted to DKK 24,221,286.